September 26, 2019
cTAP’s insights to assist the design and analysis of clinical trials in patients with DMD
cTAP has published a comprehensive analysis of the North Star Ambulatory Assessment (NSAA), a newly adopted primary outcome measure in clinical trials of patients with Duchenne Muscular Dystrophy.